These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18022575)

  • 1. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
    Bonfim CM; de Medeiros CR; Bitencourt MA; Zanis-Neto J; Funke VA; Setubal DC; Ruiz J; Sanders JE; Flowers ME; Kiem HP; Storb R; Pasquini R
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1455-60. PubMed ID: 18022575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia.
    Zanis-Neto J; Flowers ME; Medeiros CR; Bitencourt MA; Bonfim CM; Setúbal DC; Funke V; Sanders J; Deeg HJ; Kiem HP; Martin P; Leisenring W; Storb R; Pasquini R
    Br J Haematol; 2005 Jul; 130(1):99-106. PubMed ID: 15982351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
    Satwani P; Bhatia M; Garvin JH; George D; Dela Cruz F; Le Gall J; Jin Z; Schwartz J; Duffy D; van de Ven C; Foley S; Hawks R; Morris E; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):324-9. PubMed ID: 22079471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
    Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
    Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
    Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.
    Dufour C; Rondelli R; Locatelli F; Miano M; Di Girolamo G; Bacigalupo A; Messina C; Porta F; Balduzzi A; Iorio AP; Buket E; Madon E; Pession A; Dini G; Di Bartolomeo P; ;
    Br J Haematol; 2001 Mar; 112(3):796-805. PubMed ID: 11260086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.
    Ayas M; Siddiqui K; Al-Jefri A; El-Solh H; Al-Ahmari A; Khairy A; Markiz S; Shahin H; Al-Musa A; Al-Seraihy A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1599-603. PubMed ID: 24960628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
    Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
    Thakar MS; Bonfim C; Sandmaier BM; O'Donnell P; Ribeiro L; Gooley T; Deeg HJ; Flowers ME; Pasquini R; Storb R; Woolfrey AE; Kiem HP
    Pediatr Hematol Oncol; 2012 Sep; 29(6):568-78. PubMed ID: 22839094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
    Bitan M; Or R; Shapira MY; Aker M; Resnick IB; Ackerstein A; Samuel S; Elad S; Slavin S
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):712-8. PubMed ID: 16785060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy.
    Ayas M; Al-Jefri A; Al-Mahr M; Rifai S; Al-Seraihi A; Tbakhi A; Mustafa M; Khairy A; Moussa E; Iqbal A; Shalaby L; El-Solh H
    Bone Marrow Transplant; 2005 Mar; 35(5):463-6. PubMed ID: 15654354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation.
    Flowers ME; Zanis J; Pasquini R; Deeg HJ; Ribeiro R; Longton G; Medeiros CR; Doney K; Sanders J; Bryant J
    Br J Haematol; 1996 Mar; 92(3):699-706. PubMed ID: 8616040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.